Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/03/041201
CTRI/2022/03/041201
Completed
N/A

Apremilast in childhood dermatoses

CUTIS Academy of Cutaneous Sciences0 sites15 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
CUTIS Academy of Cutaneous Sciences
Enrollment
15
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 19, 2022
Last Updated
3 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\.Children between age of 6\-17 years
  • •2\.Confirmed dermatological diseases (psoriasis, vitiligo, alopecia areata, atopic dermatitis)
  • •3\.Both male and female children will be recruited
  • •4\.Parents willing to provide written informed consent

Exclusion Criteria

  • •1\.History of any chronic systemic disease
  • •2\.History of any congenital anomaly
  • •3\.Patients with active infection
  • •4\.Participated in a clinical trial in last 90 days
  • •5\.Parents not willing to provide written informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not Yet Recruiting
N/A
Predictive value of skin conductance monitoring and assessment of heart rate variability for postoperative pain in paediatric patientsAcute postoperative painAnaesthesiology - Anaesthetics
ACTRN12609000583246Prof. Thomas Ledowski150
Completed
N/A
Skin Adverse Reactions Occuring in Children Treated by Biotherapy for Chronic Inflammatory DiseaseBiotherapyChronic Inflammatory DiseaseAllergic Skin ReactionPediatric DisorderDermatologic ComplicationGastrointestinal DiseaseOphthalmologyRheumatology
NCT04327752Centre Hospitalier Universitaire, Amiens20
Active, Not Recruiting
Phase 3
Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Than 12 Years of Age in Japan With Moderate to Severe Atopic DermatitisAtopic Dermatitis
NCT06701331AbbVie99
Terminated
Phase 2
A single-blind randomised controlled trial of topical Kanuka honey for the treatment of Nappy Rashappy RashNappy RashSkin - Dermatological conditions
ACTRN12614000002684Honeylab Ltd138
Completed
N/A
Probiotics in Atopic Dermatitis in Infancy
ISRCTN41490500Wythenshawe Hospital (UK)250